These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5384674)

  • 21. Methysergide maleate (Sansert) and the prevention of migraine.
    Kabler JD
    Wis Med J; 1967 Sep; 66(9):435-6. PubMed ID: 6075108
    [No Abstract]   [Full Text] [Related]  

  • 22. Migraine, methysergide (sansert), basophile degranulation and schizophrenic children.
    J Asthma Res; 1966 Sep; 4(1):1-3. PubMed ID: 5957542
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the role of methysergide in the therapy of scleroderma].
    Stern P; Grin E; Salamon T
    Allerg Asthma (Leipz); 1965; 11(4):150-2. PubMed ID: 5887077
    [No Abstract]   [Full Text] [Related]  

  • 24. [Deseril (methysergide) in the treatment of vascular migraine headache].
    Zec N; Bokonjić R
    Neuropsihijatrija; 1964; 12(1-4):137-45. PubMed ID: 16305167
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical trials of vasoactive and antiserotonin drugs in Duchenne muscular dystrophy.
    Patten BM; Zeller RS
    Ann Clin Res; 1983 Aug; 15(4):164-6. PubMed ID: 6360027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective and non-selective beta-blockers: are both effective in prophylaxis of migraine? A clinical trial versus methysergide.
    Steardo L; Bonuso S; Di Stasio E; Marano E
    Acta Neurol (Napoli); 1982 Jun; 4(3):196-204. PubMed ID: 7136885
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral vasospasm. Part I. In cerebral vascular malformations.
    Mohr JP; Kase CS
    Rev Neurol (Paris); 1983; 139(2):99-113. PubMed ID: 6410488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ischemic pituitary apoplexy and cerebrovascular accident].
    D'Haens J; Baleriaux D; Mockel J; Flament-Durand J; Brotchi J
    Neurochirurgie; 1983; 29(6):401-5. PubMed ID: 6664402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Certain possibilities for ultrasonic methods in the evaluation of the status of the venous component of cerebral hemodynamics (clinico-experimental study)].
    Stulin ID; Karlov VA; Skorunskiĭ IA; Shmyrev VI; Teplova LP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):65-9. PubMed ID: 7234264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methysergide induced mitral valvular insufficiency.
    Salner AL; Mullany LD; Cole SR
    Conn Med; 1980 Jan; 44(1):6-8. PubMed ID: 7353368
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic potential of endothelin receptor antagonists in experimental stroke.
    Patel TR; Galbraith SL; McAuley MA; Doherty AM; Graham DI; McCulloch J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S412-5. PubMed ID: 8587430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of gamma-aminobutyric acid preparations on cerebral circulation in chronic cerebrovascular insufficiency].
    Eninia GI; Smeltere ES; Godlevska MA; Uzulinia IP
    Klin Med (Mosk); 1982 Oct; 60(10):47-50. PubMed ID: 7176473
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of methysergide in manic states.
    Haskovec L; Soucek K
    Act Nerv Super (Praha); 1968 Oct; 10(3):309-10. PubMed ID: 5702541
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the incidence of ocular disorders in severe migraine, common migraine and migraine states. Evaluation of the results obtained with medical and oculistic therapy].
    Nattero G; Gastaldi L; Gai V
    Riv Crit Clin Med; 1968; 68():Suppl 6:1001+. PubMed ID: 5747745
    [No Abstract]   [Full Text] [Related]  

  • 36. Current status of intraneural phenol injections.
    Mooney V; Frykman G; McLamb J
    Clin Orthop Relat Res; 1969; 63():122-31. PubMed ID: 5769368
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical and experimental studies on the role of Ca++ in etiology of cerebral vasospasm].
    Abe S
    No Shinkei Geka; 1983 Nov; 11(11):1157-64. PubMed ID: 6582363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dynamic spasm of the cerebral arteries in stenosis on account of arteritis].
    Lerman VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(3):338-42. PubMed ID: 5795716
    [No Abstract]   [Full Text] [Related]  

  • 39. Interference of methysergide, a specific 5-hydroxytryptamine receptor antagonist, with airway chronic allergic inflammation and remodelling in a murine model of asthma.
    Lima C; Souza VM; Soares AL; Macedo MS; Tavares-de-Lima W; Vargaftig BB
    Clin Exp Allergy; 2007 May; 37(5):723-34. PubMed ID: 17456220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacology of the neural regulation of cerebral circulation (clinico-experimental study)].
    Mirzoian RS; Maĭorchik VE; Anzimirov VL; Gasanov IaK; Kornienko VN
    Farmakol Toksikol; 1982; 45(3):94-7. PubMed ID: 6807717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.